Afatinib Osimertinib Sequencing NIS

Clinical trial NCT03370770 · COMPLETED

Trial details

NCT number: NCT03370770
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Study type: OBSERVATIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2017-12-28
Primary completion: 2019-11-28
Enrollment: 204

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.